A citation-based method for searching scientific literature

C T M Brekelmans, M M A Tilanus-Linthorst, C Seynaeve, A vd Ouweland, M B E Menke-Pluymers, C C M Bartels, M Kriege, A N van Geel, C W Burger, A M M Eggermont, H Meijers-Heijboer, J G M Klijn. Eur J Cancer 2007
Times Cited: 148



Gad Rennert, Shantih Bisland-Naggan, Ofra Barnett-Griness, Naomi Bar-Joseph, Shiyu Zhang, Hedy S Rennert, Steven A Narod. N Engl J Med 2007
Times Cited: 206




List of shared articles



Times cited

Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study.
Mark van Barele, Amy Rieborn, Bernadette A M Heemskerk-Gerritsen, Inge-Marie Obdeijn, Linetta B Koppert, Claudette E Loo, Rob A E M Tollenaar, Margreet G E M Ausems, Irma van de Beek, Lieke P V Berger,[...]. Breast Cancer Res Treat 2022
0

Incidence of contralateral and ipsilateral breast cancers and prognosis in BRCA1/2 pathogenic variant carriers based on the Japanese HBOC Consortium registration.
Akiyo Yoshimura, Shiro Yokoyama, Hiroji Iwata, Nobue Takaiso, Tadashi Nomizu, Masami Arai, Seigo Nakamura. J Hum Genet 2021
0


Prognostic Impact of BRCA1 and BRCA2 Mutations on Long-Term Survival Outcomes in Egyptian Female Breast Cancer Patients.
Sherihan AbdelHamid, Hala El-Mesallamy, Hany Abdel Aziz, Abdel-Rahman Zekri. Biology (Basel) 2021
1

Pathology of BRCA1- and BRCA2-associated Breast Cancers: Known and Less Known Connections.
Elena Fountzilas, Irene Konstantopoulou, Andromahi Vagena, Paraskevi Apostolou, Christos Papadimitriou, Christos Christodoulou, Dimitrios Tryfonopoulos, Kyriaki Manousou, Angeliki Delimitsou, Myrto Papamentzelopoulou,[...]. Clin Breast Cancer 2020
4

Association of gBRCA1/2 mutation locations with ovarian cancer risk in Japanese patients from the CHARLOTTE study.
Kosuke Yoshihara, Takayuki Enomoto, Daisuke Aoki, Yoh Watanabe, Junzo Kigawa, Nobuhiro Takeshima, Hyoe Inomata, Kana Hattori, Masahisa Jinushi, Hitoshi Tsuda,[...]. Cancer Sci 2020
5


Oestrogen receptor status and survival in women with BRCA2-associated breast cancer.
Kelly Metcalfe, Henry T Lynch, William D Foulkes, Nadine Tung, Olufunmilayo I Olopade, Andrea Eisen, Jordan Lerner-Ellis, Carrie Snyder, Shana J Kim, Ping Sun,[...]. Br J Cancer 2019
9

Germline breast cancer susceptibility gene mutations and breast cancer outcomes.
Yong Alison Wang, Jhih-Wei Jian, Chen-Fang Hung, Hung-Pin Peng, Chi-Fan Yang, Hung-Chun Skye Cheng, An-Suei Yang. BMC Cancer 2018
35



Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients.
Jie Sun, Hua Meng, Lu Yao, Meng Lv, Jian Bai, Jianguang Zhang, Lientu Wang, Tao Ouyang, Jinfeng Li, Tianfeng Wang,[...]. Clin Cancer Res 2017
92

Survival in familial and non-familial breast cancer by age and stage at diagnosis.
Elham Kharazmi, Asta Försti, Kristina Sundquist, Kari Hemminki. Eur J Cancer 2016
2

Interaction between Hormonal Receptor Status, Age and Survival in Patients with BRCA1/2 Germline Mutations: A Systematic Review and Meta-Regression.
Arnoud J Templeton, Laura Diez Gonzalez, Francisco E Vera-Badillo, Ariadna Tibau, Robyn Goldstein, Boštjan Šeruga, Amirrtha Srikanthan, Atanasio Pandiella, Eitan Amir, Alberto Ocana. PLoS One 2016
16

Tumor characteristics and prognosis in familial breast cancer.
G Arpino, M Pensabene, C Condello, R Ruocco, I Cerillo, R Lauria, V Forestieri, M Giuliano, C De Angelis, M Montella,[...]. BMC Cancer 2016
10

Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysis.
Qian Zhong, Hong-Ling Peng, Xia Zhao, Lin Zhang, Wei-Ting Hwang. Clin Cancer Res 2015
114


Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis.
Alexandra J van den Broek, Marjanka K Schmidt, Laura J van 't Veer, Rob A E M Tollenaar, Flora E van Leeuwen. PLoS One 2015
52


BRCA1/2 and clinical outcome in a monoinstitutional cohort of women with hereditary breast cancer.
Domenico Sambiasi, Rossana Lambo, Brunella Pilato, Stefania Tommasi, Giuseppe Trojano, Anila Kardhashi, Maria Digennaro, Vito Trojano, Gianni Simone, Angelo Paradiso. Oncol Rep 2014
6

Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis.
Antonis Valachis, Andreas D Nearchou, Pehr Lind. Breast Cancer Res Treat 2014
76

Opportunities and challenges of next-generation DNA sequencing for breast units.
S M Pilgrim, S J Pain, M D Tischkowitz. Br J Surg 2014
5

Outcome of metastatic breast cancer in selected women with or without deleterious BRCA mutations.
S Bayraktar, A M Gutierrez-Barrera, H Lin, N Elsayegh, T Tasbas, J K Litton, N K Ibrahim, P K Morrow, M Green, V Valero,[...]. Clin Exp Metastasis 2013
23

Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.
Dana Meaney-Delman, Cecelia A Bellcross. Obstet Gynecol Clin North Am 2013
7



Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: further evidence of benefit.
Andrew Maurice, D Gareth Evans, Jenny Affen, Rosemary Greenhalgh, Stephen W Duffy, Anthony Howell. Int J Cancer 2012
20

Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study.
Pamela J Goodwin, Kelly-Anne Phillips, Dee W West, Marguerite Ennis, John L Hopper, Esther M John, Frances P O'Malley, Roger L Milne, Irene L Andrulis, Michael L Friedlander,[...]. J Clin Oncol 2012
98

Online tool to guide decisions for BRCA1/2 mutation carriers.
Allison W Kurian, Diego F Munoz, Peter Rust, Elizabeth A Schackmann, Michael Smith, Lauren Clarke, Meredith A Mills, Sylvia K Plevritis. J Clin Oncol 2012
57